New inflammatory indicators for cell-based liquid biopsy: association of the circulating CD44+/CD24− non-hematopoietic rare cell phenotype with breast cancer residual disease

BACKGROUND: Breast cancer residual disease assessment in early-stage patients has been challenging and lacks routine identification of adjuvant therapy benefit and objective measure of therapy success. Liquid biopsy assays targeting tumor-derived entities are investigated for minimal residual diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreier, Stefan, Budchart, Prapaphan, Borwornpinyo, Suparerk, Arpornwirat, Wichit, Lertsithichai, Panuwat, Chirappapha, Prakasit, Triampo, Wannapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470072/
https://www.ncbi.nlm.nih.gov/pubmed/36100762
http://dx.doi.org/10.1007/s00432-022-04330-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470072/
https://www.ncbi.nlm.nih.gov/pubmed/36100762
http://dx.doi.org/10.1007/s00432-022-04330-5

Ejemplares similares